City
Epaper

Pinworm medication may treat aggressive skin cancer: Researchers

By IANS | Updated: April 20, 2025 11:22 IST

New York, April 20 A team of US scientists has found that a common pinworm medication may stop ...

Open in App

New York, April 20 A team of US scientists has found that a common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer.

The research led by University of Arizona Cancer Center and published in the Journal of Clinical Investigation, found that in laboratory models of Merkel cell carcinoma, pyrvinium pamoate inhibited cancer cell growth and reversed the cancer’s neuroendocrine features.

In mouse models of Merkel cell carcinoma, pyrvinium pamoate reduced tumour growth.

Merkel cell carcinoma is a rare but fast-growing neuroendocrine cancer that is three to five times more likely than melanoma to be deadly. Response rates to current therapies – surgery, radiation and immunotherapy – are limited, resulting in a need for effective and broadly applicable therapeutics.

“Merkel cell carcinoma is increasing in incidence. Even though it’s a rare cancer type, it mimics a lot of properties that other cancers have,” said senior author Megha Padi, assistant professor at the university.

Pyrvinium pamoate, a medication approved by the Food and Drug Administration in 1955 to treat pinworms, has been shown to have antitumour potential in several different cancers, including breast, colorectal, pancreatic and bladder cancers. This is the first time it has been studied in models of Merkel cell carcinoma.

Padi and the research team found that in laboratory models of Merkel cell carcinoma, pyrvinium pamoate inhibited cancer cell growth and reversed the cancer’s neuroendocrine features. In mouse models of Merkel cell carcinoma, pyrvinium pamoate reduced tumor growth.

“This is a hypothesis, but some people think the reason an antiparasitic agent could be effective against cancers is because tumours are a little bit like parasites in our body,” Padi said. “Parasites and tumours must develop ways to use scarce resources in their host to feed themselves and allow for unlimited multiplication. If the pathways that they have hijacked to feed themselves are the same, then you get lucky, and you have a tumour type that could be amenable to killing by these antiparasitic drugs.”

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalEgyptian, Palestinian PMs discuss developments in Palestine

InternationalPak PM's Coordinator expresses fear over 1,000 deaths in KP flash floods

InternationalIsrael airdrops 161 food aid packages in Gaza with support from nine countries

InternationalIsraeli army chief to begin Gaza City assault 'soon'

InternationalIndian Consulate in New York marks Independence Day with grand India Day Parade

Health Realted Stories

HealthBangladesh: One more person dies of dengue, 2025 toll rises to 105

HealthPrevention, not just medication, key to tackling obesity and diabetes: Jitendra Singh

HealthAyush seminar to boost ayurveda‑based paediatric healthcare

HealthIIT Kharagpur launches healthcare and technology school to train youth as health professionals

HealthNovel live type 1, 3 oral polio vaccines show promise in phase 1 trial